FASSI, ENRICO MARIO ALESSANDRO
FASSI, ENRICO MARIO ALESSANDRO
Dipartimento di Scienze Farmaceutiche
Targeted degraders of eIF6: a novel strategy to remodulate liver pathological lipidic metabolism
2024 A. Colleoni, E.M.A. Fassi, A. Miluzio, M. Albani, D. Lecchi, G. Tempra, M. DE AMICI, G. Grazioso, S. Biffo, C. Matera
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists
2024 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, E.M.A. Fassi, G. Grazioso, F. Meneghetti, S. Villa
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines
2024 M. Albani, E.M.A. Fassi, R.M. Moretti, M. Garofalo, M. Montagnani Marelli, G. Roda, J. Sgrignani, A. Cavalli, G. Grazioso
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists
2024 S. Ciceri, E.M.A. Fassi, V. Vezzoli, M. Bonomi, D. Colombo, P. Ferraboschi, G. Grazioso, P. Grisenti, S. Villa, C. Castellano, F. Meneghetti
PCSK9 inhibitors: a patent review 2018-2023
2024 E.M.A. Fassi, A. Citarella, M. Albani, E.G. Milano, L. Legnani, C. Lammi, A. Silvani, G. Grazioso
Tackling Hepatocellular Carcinoma with Targeted Degraders of eIF6
2024 A. Colleoni, E.M.A. Fassi, A. Miluzio, M. Albani, D. Lecchi, M. De Amici, G. Grazioso, S. Biffo, C. Matera
High‐throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development
2024 M. Bombaci, E.M.A. Fassi, A. Gobbini, D. Mileto, I. Cassaniti, E. Pesce, E. Casali, A. Mancon, J. Sammartino, A. Ferrari, E. Percivalle, R. Grande, E. Marchisio, M.R. Gismondo, S. Abrignani, F. Baldanti, G. Colombo, R. Grifantini
Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity
2023 C. Lammi, E.M.A. Fassi, M. Manenti, M. Brambilla, M. Conti, J. Li, G. Roda, M. Camera, A. Silvani, G. Grazioso
A new class of GnRH receptor modulators endowed with atropisomerism
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Insights on the atropisomeric properties of elagolix and its derivatives
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid
2023 A. Ratti, E.M.A. Fassi, F. Forlani, M. Mori, F. Villa, F. Cappitelli, J. Sgrignani, G. Roda, A. Cavalli, S. Villa, G. Grazioso
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
2023 S. Ciceri, D.R. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, M. Iannone, C. Castellano, F. Meneghetti
COMPUTATIONAL DESIGN OF PEPTIDES AND PEPTIDOMIMETICS AS POTENTIAL THERAPEUTIC AGENTS TO SATISFY PRESSING MEDICAL NEEDS
2023 E.M.A. Fassi
Natural and nature-inspired compounds targeting E. coli WrbA as antibiofilm agents: computational studies, synthesis, and biological evaluation
2023 M. Mori, S. Villa, A. Ratti, F. Meneghetti, G. Roda, A. Gelain, F. Villa, E.M.A. Fassi, F. Forlani, G. Grazioso
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, M. Quaglia, G. Grazioso, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS.
2023 G. Cazzaniga, M. Mori, D. Capelli, R. Montanari, A. Laghezza, F. Loiodice, I. Bassanini, S. Romeo, E.M.A. Fassi, G. Grazioso, M. Quaglia, F. Meneghetti, S. Villa
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors
2023 E.M.A. Fassi, M. Manenti, A. Citarella, M. Dei Cas, S. Casati, N. Micale, T. Schirmeister, G. Roda, A. Silvani, G. Grazioso
Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA
2023 A. Ratti, E.M.A. Fassi, F. Forlani, M. Zangrossi, M. Mori, F. Cappitelli, G. Roda, S. Villa, F. Villa, G. Grazioso
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands
2023 M.A. Chiacchio, L. Legnani, E.M.A. Fassi, G. Roda, G. Grazioso